ImmunoTherapy Bridge 2023
S

Novel Insights Into the Mechanisms of Radiation-Induced Anti-Tumor Immunity

By ImmunoTherapy Bridge 2023 FEATURING Sandra Demaria
By ImmunoTherapy Bridge 2023 FEATURING Sandra Demaria
105 views
January 10, 2024
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
07:11
GRACE

CAR T-Cell vs. Bispecific Therapies for Blood Cancers: How Oncologis…

Feat. A. Goodman, A. Jeong, S. Rajeeve
06:47
UCSF School of Medicine

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…

Feat. H. Kang
45:56
Yale Cancer Center

Endocrine Adverse Events From Checkpoint Inhibitors

Feat. K. Herold
06:57
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ESR1 Mutational Landscape and Impact of C…

Feat. A. Medford
41:07
Yale Cancer Center

Understanding Your Cancer Risk and Options for Cancer Prevention

Feat. V. Giri, T. Shroff
23:00
Total Health

ctDNA and MRD: Who, What, and Then What?

Feat. A. Parikh
04:08
GRACE

CAR T-Cell Therapy Side Effects for Blood Cancers

Feat. A. Goodman
32:52
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

The Improbable History of CAR T-Cells

Feat. C. June
19:05
International Congress on Cancer Metastasis

Could We Cure Metastatic Breast Cancer?

Feat. L. Pusztai
21:23
2023 Evolution Conference

Comprehensive Genomic Profiling: Why Aren't We Doing It?

Feat. J. Meisel
67:04
European School of Oncology

Basic Principles of Tumor Immunology

Feat. M. van den Broek
18:46
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

Biomarkers in Immuno-Oncology: Road to Personalized Immunotherapy

Feat. C. Jackson
15:24
Michael Soulen

Interventional Delivery of CAR-T Therapy

20:31
Total Health

Diagnostics: Genomics for Treatment Planning of Breast Cancer

Feat. R. L. Mahtani
09:48
ecancer

ESMO 2022 on the PATHFINDER Study: A New Era of Early Cancer Detecti…

Feat. D. Schrag
14:27
ecancer

Latest in Lung Cancer Genomic Testing

Feat. S. Popat
25:24
Beth Israel Deaconess Medical Center

CAR T-Cell Failure: Mechanisms and Salvage Options

Feat. J. Arnason
11:26
ImmunoTherapy Bridge 2023

Bispecific vs. Combination Therapy - PRO Bispecific

Feat. J. Gulley
20:06
ImmunoTherapy Bridge 2023

Bispecific vs. Combination Therapy - PRO Combination Therapy

Feat. A. Patnaik
08:04
ASCO 2022 Conference Coverage

ASCO 2022 on OPTIMA Preliminary Trial: Disparity Between Ki67 Measur…

Feat. R. Stein